• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Eli Lilly

Graphic for Fierces Podnosis podcast featuring concentric soundwave circles around a stylized red heart at the center The
Podcast

An insider’s look at LillyDirect

Senior Writer Anastassia Gliadkovskaya speaks with LillyDirect executive Jen Mazur about the platform’s growth, purpose and future plans.
Anastassia Gliadkovskaya , Ayla Ellison May 27, 2026 10:30am
man wearing blood pressure cuff and looking at smartphone while sitting at table

Omada, Eli Lilly partner on direct-to-employer GLP-1 channel

May 11, 2026 7:00am
Ozempic Wegovy

Him & Hers now offers all FDA-approved GLP-1s

Apr 23, 2026 10:43am
Eli Lilly Lilly

Eli Lilly’s GLP-1 pill rolls out via US telehealth providers

Apr 9, 2026 11:45am
Eli Lilly Zepbound KwikPens

Eli Lilly launches its direct-to-employer platform for GLP-1s

Mar 5, 2026 6:00am
drugs coins pharma

Hospitals decry drugmakers' expanded 340B reporting policies

Mar 4, 2026 5:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings